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Rubinstein–Taybi syndrome is an extremely rare plurimalformative condition that can affect any organ. However, reports
regarding gynecological problems are unusual. We report the first case of a septate uterus in an adolescent with this syndrome,
in agreement with the American Society for Reproductive Medicine (ASRM) and the Congenital Uterine Malformations by
Expert (CUME) criteria for uterine septum. Additional studies are required to determine whether there is an increased frequency
of mu¨llerian duct anomalies with the condition. Our report extends the data on the clinical phenotype associated with
Rubinstein–Taybi syndrome.
1. Introduction
Rubinstein–Taybi syndrome (RSTS; OMIM 180849) is an
extremely rare plurimalformative condition that was first
described in 1963 [1]. &e syndrome is almost always a de
novo occurring autosomal entity [2]. RSTS can be caused by
heterozygous mutations in CREBBP gene or less commonly
the EP300 gene, which are involved in several basic cellular
activities including growth and differentiation. Although
nearly 45% of cases have no identifiable mutation, there are
no precise clinical diagnostic criteria [2, 3]. Classical features
include postnatal growth retardation, microcephaly, dis-
tinctive facial characteristics, broad thumbs and big toes,
and intellectual disability [4, 5]. Data on children and
adults with RSTS have been extensively gathered in many
areas to guide decisions in medical care of these patients.
However, case reports regarding gynecologic health care in
RSTS are particularly rare in the literature. Here, we report
a first case of a septate uterus in a girl with RSTS. Our
objectives are to highlight this unreported clinical finding
and to discuss the importance of gynecological development
evaluation to appropriate management and follow-up care of
RSTS girls.
2. Case
A 13-year-old girl was referred with the complaint of
spotting since menarche at age 12 years. She was known to
have clinical diagnosis of RSTS with normal genetic studies.
&e condition affected her ability to care for herself, and she
was living in a state-supported institution for children with
intellectual disability since her parents’ divorce. She had no
history of dysmenorrhea, sexual intercourse, nor previous
gynecological examination. Clinical examination at pre-
sentation was unremarkable, except an increased body mass
index. Serum human chorionic gonadotropin level was within
nonpregnant levels. Complete blood count, clotting screens,
and thyroid function tests were in the normal ranges.
Transabdominal ultrasound examination showed a normal
size uterus with two endometrial cavities both with a regular
endometrium with a thickness of 13.5mm (Figure 1) and
normal ovaries. MRI confirmed the presence of two
endometrial cavities separated by a small midline septum
without proximity to the internal os. &e flat fundus with an
internal indentation depth of 16.7mm and an indentation
angle of 75° was consistent with a partial septate uterus (Figure 2)
(according to the Congenital Uterine Malformations by Expert
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(CUME) criteria and the American Society for Reproductive
Medicine (ASRM) classification system of female tract con-
genital anomalies). Coexistent renal abnormalities were
excluded.
&e patient was started on cyclical progestogen for
dysfunctional uterine-bleeding management. She became
asymptomatic and had regular menses with normal men-
strual bleeding during a 4-month follow-up period. &e
management of the partial septate uterus needed nothing
more than reassurance. Parental consent was given and
a progestogen-only implant was inserted to prevent the risk of
unintended pregnancy.
3. Discussion
RSTS is a dominantly inherited syndrome characterized by
multiple congenital anomalies and mental retardation, with
an estimated birth prevalence of one in 100,000–125,000 live
births. About 50% of archetypical RSTS carry deletions or
mutations of CREBPP gene; mutations in EP300 gene have
also been detected, but cytogenetic and molecular studies
with negative results do not exclude the diagnosis [2, 3].
Most of RSTS cases are still currently diagnosed based on
characteristic features [5]. Besides the classic phenotype
previously described, several birth defects have been re-
ported to occur in persons with RSTS; however, congenital
uterine malformations are not typically known to be asso-
ciated with the syndrome.
A septate uterus can occur during embryonic life due to
defective regression of the midline septum uniting the two
mu¨llerian ducts. Uterine malformations are commonly as-
sociated with renal anomalies because of the close embryo-
logical origin of the renal and genital tracts. An interesting
remark is that renal anomalies are considered a typical feature
of RSTS, and all children with the syndrome should receive
a baseline renal ultrasound [4, 5].When a single septate uterus
is diagnosed, urinary malformations are usually absent [6, 7],
which is consistent with the current report.
Distinguishing between septate and normal/arcuate
uterus, it is point of ongoing debate among experts. &e
is image is not for diagnostic purposes is image is not for diagnostic purposes
Figure 1: Ultrasound images showing a normal size uterus with two endometrial cavities both with a regular endometrium.
Figure 2: MRI and coronal view of the septate uterus. Internal indentation depth is 16.7mm and the indentation angle is 75°, with
a normal external fundal contour, and these measurements are in agreement with the definition for septate uterus by the ASRM and the
CUME [7, 8].
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risks of overdiagnosis and overtreatment of septate uterus
diagnosis by the European Society of Human Reproduction
and Embryology-European Society for Gynaecological En-
doscopy (ESHR–ESGE) classification of mu¨llerian duct
anomalies are higher, when compared to the ASRM and
CUME criteria [8, 9]. As recommended for daily practice, we
classified this reported congenital uterine anomaly using the
CUME reference standard (internal indentation depth≥ 10mm)
as septate uterus, in agreement with experts’ opinion from
different societies in the field [8]. &e recognition of the septum
was also in agreement with the ASRM criteria (indentation
depth>15mm and indentation angle<90°) [7].
RSTS management strategies are symptomatic [2, 4]. &e
same reasoning should be used to congenital uterus mal-
formations. In the present case report, expectantmanagement
was a suitable option facing the incidental finding of a
mu¨llerian anomaly: (i) our case describes a minor female with
genital tract malformation; (ii) our patient was asymptomatic:
as the spotting complaints could not be justified by the
presence of a partial septum, she had no dysmenorrhea, and
septate uterus is associated especially with obstetrical prob-
lems; and (iii) surgical repair with resection of the septum is
primarily directed to improve pregnancy outcome; however,
there are no randomized controlled trials confirming benefits
and safety of such procedures [7].
&e great majority of RSTS patients, such as the present
one, have a manifest cognitive delay which itself accounts
for RSTS women be considered a high-risk obstetric
population. Although global mental retardation is char-
acteristic, RSTS patients have a marked ability to establish
excellent social contacts and can reproduce [2]. If a uterine
malformation has been detected, the obstetric risk could
be higher. Congenital anomalies of the uterus typically do
not prevent conception and implantation [6]. &erefore,
a critical aspect is to assess contraceptive need as initially
indicated in RSTS medical guidelines [4]. To avoid un-
intended pregnancy, we recommended and have provided
a long-acting reversible contraception, that is, an
etonogestrel-containing subcutaneous implant to our ad-
olescent patient.
Medical guidelines proposed by Wiley et al. in 2003
include gynecological evaluation of RSTS females [4], but the
same is not seen in a recent proposal for update health care
and follow-up care of RSTS [5]. However, the authors
mention that RSTS management should be adjusted in
adolescent age, and that, further investigation should also
focus clinical diagnosis for refinement of guidelines [5]. Each
RSTS female should have an individualized approach to
gynecologic health care, given the complexity and rarity of
the condition. We also suggest careful surveillance during
adolescence, in order to increase the chances to uncover
gynecological problems during this particular time which is
already marked by great physical and mental changes. It is
imperative to treat RSTS girls with particular patience and
skill. Evaluation by a gynecologist knowledgeable in caring
for adolescents with developmental disabilities is warranted.
Early referral based on presenting symptoms allows a col-
laborative effort for better management and follow-up care
of RSTS female patients.
RSTS is a plurimalformative syndrome that can affect
any organ [5]. We describe for the first time a septate uterus
in an RSTS girl. To date, there is one prior reference to
a patient with RSTS who had a bifid uterus associated with
menometrorrhagia, but details are not known [4]. Addi-
tional studies are required to determine whether there is an
increased frequency of mu¨llerian duct anomalies with the
condition. Mu¨llerian defects are not infrequently observed
inmalformation syndromes [5]. Butmany uterine anomalies
are an asymptomatic incidental finding as in our report. As
previously discussed, abnormal embryologic development of
the uterus is frequently associated with urologic malfor-
mations [6]. It is unclear if this can be extrapolated to the
females among the 52% of patients with RSTS who exhibit
renal malformations [4, 5]. &e underlying etiology of
congenital uterine defects is not well understood [6, 10].
Research regarding RSTS etiopathogenesis is in progress
[3, 5]. No cytogenetic or molecular abnormality has been
detected in our patient, and therefore, no genotype/phenotype
correlation can be theorized.
Ultimately, our report extends the data on the clinical
phenotype associated with this extremely rare multiple
congenital anomaly. With the publication of similar cases,
the attention of clinicians and researchers in the field of
RSTS will be brought to gynecological development evalu-
ation, providing best practice in medical care of female
patients with RSTS.
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